BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 16421802)

  • 41. Relevance of human papillomavirus screening in management of cervical intraepithelial neoplasia.
    Kaufman RH; Adam E; Icenogle J; Lawson H; Lee N; Reeves KO; Irwin J; Simon T; Press M; Uhler R; Entman C; Reeves WC
    Am J Obstet Gynecol; 1997 Jan; 176(1 Pt 1):87-92. PubMed ID: 9024095
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Linear array genotyping and hybrid capture II assay in detecting human papillomavirus genotypes in women referred for colposcopy due to abnormal Papanicolaou smear.
    Monsonego J; Pollini G; Evrard MJ; Sednaoui P; Monfort L; Quinzat D; Dachez R; Syrjänen K
    Int J STD AIDS; 2008 Jun; 19(6):385-92. PubMed ID: 18595876
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cervical Precancer Risk in HIV-Infected Women Who Test Positive for Oncogenic Human Papillomavirus Despite a Normal Pap Test.
    Keller MJ; Burk RD; Massad LS; Eltoum IE; Hessol NA; Castle PE; Anastos K; Xie X; Minkoff H; Xue X; D'Souza G; Flowers L; Levine AM; Colie C; Rahangdale L; Fischl MA; Palefsky JM; Strickler HD
    Clin Infect Dis; 2015 Nov; 61(10):1573-81. PubMed ID: 26187020
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Naked-eye inspection of the cervix after acetic acid application may improve the predictive value of negative cytologic screening.
    Frisch LE; Milner FH; Ferris DG
    J Fam Pract; 1994 Nov; 39(5):457-60. PubMed ID: 7755697
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human papilloma virus testing knowledge and attitudes among women attending colposcopy clinic with ASCUS/LGSIL pap smears.
    Le T; Hicks W; Menard C; Boyd D; Hewson T; Hopkins L; Kee Fung MF
    J Obstet Gynaecol Can; 2004 Sep; 26(9):788-92. PubMed ID: 15361273
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparing cytology, colposcopy and human papillomavirus cervical intraepithelial lesion screening methods in women with systemic lupus erythematosus.
    García-Carrasco M; Mendoza-Pinto C; Méndez-Martínez S; Rodríguez-Reyes A; Munguía-Realpozo P; Taboada-Cole A; Vallejo-Ruiz V; Etchegaray-Morales I; Jiménez-Herrera R; Juárez-Melchor D; Villanueva-López I
    Lupus; 2020 Aug; 29(9):1060-1066. PubMed ID: 32501171
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Natural history of false-negative papanicolaou smears: a prospective study using screening colposcopy in addition to cytology.
    Mannino JR
    J Am Osteopath Assoc; 1998 Oct; 98(10):542-6. PubMed ID: 9821735
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High-risk HPV DNA detection by Hybrid Capture II. An adjunctive test for mildly abnormal cytologic smears in women > or = 50 years of age.
    Lin CT; Tseng CJ; Lai CH; Hsueh S; Huang HJ; Law KS
    J Reprod Med; 2000 Apr; 45(4):345-50. PubMed ID: 10804494
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Previous Papanicolaou and Hybrid Capture 2 human papillomavirus testing results of 5699 women with histologically diagnosed cervical intraepithelial neoplasia 2/3.
    Wu T; Chen X; Zheng B; Li J; Xie F; Ding X; Zeng Z; Zhao C
    J Am Soc Cytopathol; 2019; 8(4):206-211. PubMed ID: 31272603
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human papillomavirus testing in primary cervical screening and abnormal Papanicolaou management.
    Cox JT
    Obstet Gynecol Surv; 2006 Jun; 61(6 Suppl 1):S15-25. PubMed ID: 16729900
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation.
    Verguts J; Bronselaer B; Donders G; Arbyn M; Van Eldere J; Drijkoningen M; Poppe W
    BJOG; 2006 Nov; 113(11):1303-7. PubMed ID: 16978225
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The clinical significance of the poor correlation of cervical dysplasia and cervical malignancy with referral cytologic results.
    Lonky NM; Sadeghi M; Tsadik GW; Petitti D
    Am J Obstet Gynecol; 1999 Sep; 181(3):560-6. PubMed ID: 10486464
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors, and validity of Papanicolaou smears. New York Cervical Disease Study.
    Wright TC; Ellerbrock TV; Chiasson MA; Van Devanter N; Sun XW
    Obstet Gynecol; 1994 Oct; 84(4):591-7. PubMed ID: 8090399
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Colposcopy and cervical biopsy in patients with routine Papanicolaou smear].
    Milla Villeda RH; Alvarado Zaldívar G; Sánchez Anguiano LF; Barrera Tovar M; Vázquez Arreola I
    Ginecol Obstet Mex; 1997 Jun; 65():235-8. PubMed ID: 9273333
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of the AMPLICOR human papillomavirus test and the hybrid capture 2 assay for detection of high-risk human papillomavirus in women with abnormal PAP smear.
    De Francesco MA; Gargiulo F; Schreiber C; Ciravolo G; Salinaro F; Manca N
    J Virol Methods; 2008 Jan; 147(1):10-7. PubMed ID: 17854914
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of two tests for detecting carcinogenic HPV in women with Papanicolaou smear reports of ASCUS and LSIL.
    Ferris DG; Wright TC; Litaker MS; Richart RM; Lorincz AT; Sun XW; Woodward L
    J Fam Pract; 1998 Feb; 46(2):136-41. PubMed ID: 9487319
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cervical-vaginal disease in HIV immunosuppressed patients: management and present screening programme.
    Di Stefano L; Coppola G; Moro S; Colageo E; Cellini A; Coletti G
    Eur J Gynaecol Oncol; 2006; 27(3):267-70. PubMed ID: 16800255
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Presence of human papillomavirus infection of the uterine cervix as determined by different detection methods in a low-risk community-based population.
    Zazove P; Reed BD; Gregoire L; Gorenflo DW; Lancaster WD; Ruffin MT; Hruszczyk J
    Arch Fam Med; 1993 Dec; 2(12):1250-8. PubMed ID: 8130906
    [TBL] [Abstract][Full Text] [Related]  

  • 59. P16(INK4a) immunocytochemistry in liquid-based cytology samples in equivocal Pap smears: added value in management of women with equivocal Pap smear.
    Monsonego J; Pollini G; Evrard MJ; Sednaoui P; Monfort L; Quinzat D; Dachez R; Syrjänen K
    Acta Cytol; 2007; 51(5):755-66. PubMed ID: 17910346
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk factors, diagnosis and prognosis of cervical intraepithelial neoplasia among HIV-infected women.
    Lehtovirta P; Paavonen J; Heikinheimo O
    Int J STD AIDS; 2008 Jan; 19(1):37-41. PubMed ID: 18275645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.